HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 2 filers reported holding HORIZON PHARMA PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 5.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $558,000 | +22.9% | 21,100 | -9.2% | 0.03% | -3.6% |
| Q4 2018 | $454,000 | -25.0% | 23,232 | -24.8% | 0.03% | +21.7% |
| Q3 2018 | $605,000 | +295.4% | 30,907 | +187.6% | 0.02% | +283.3% |
| Q1 2018 | $153,000 | -6.7% | 10,745 | -4.3% | 0.01% | 0.0% |
| Q4 2017 | $164,000 | +0.6% | 11,230 | -12.6% | 0.01% | -14.3% |
| Q3 2017 | $163,000 | +10.9% | 12,855 | +3.9% | 0.01% | 0.0% |
| Q2 2017 | $147,000 | -26.5% | 12,376 | -8.4% | 0.01% | -22.2% |
| Q1 2017 | $200,000 | -7.8% | 13,508 | +0.8% | 0.01% | -10.0% |
| Q4 2016 | $217,000 | -14.2% | 13,396 | -4.0% | 0.01% | -16.7% |
| Q3 2016 | $253,000 | +30.4% | 13,958 | +18.8% | 0.01% | +33.3% |
| Q2 2016 | $194,000 | -17.1% | 11,752 | +8.9% | 0.01% | -18.2% |
| Q4 2015 | $234,000 | +0.4% | 10,790 | -8.2% | 0.01% | -15.4% |
| Q3 2015 | $233,000 | – | 11,748 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,959,819 | $96,430,000 | 10.71% |
| Consonance Capital Management LP | 5,793,903 | $93,745,000 | 10.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,956,988 | $144,924,000 | 5.96% |
| JW Asset Management, LLC | 507,075 | $8,205,000 | 5.46% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 6,682,618 | $108,125,000 | 5.23% |
| NEXTHERA CAPITAL LP | 500,000 | $8,090,000 | 4.74% |
| Lion Point Capital, LP | 1,164,414 | $18,840,000 | 4.58% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 4,503,900 | $72,873,000 | 3.52% |
| ARMISTICE CAPITAL, LLC | 650,000 | $10,517,000 | 2.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 8,081,650 | $130,761,000 | 2.48% |